These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23006538)

  • 1. A nanostructured liquid crystalline formulation of 20(S)-protopanaxadiol with improved oral absorption.
    Jin X; Zhang ZH; Li SL; Sun E; Tan XB; Song J; Jia XB
    Fitoterapia; 2013 Jan; 84():64-71. PubMed ID: 23006538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.
    Jin X; Zhang ZH; Sun E; Tan XB; Li SL; Cheng XD; You M; Jia XB
    Int J Nanomedicine; 2013; 8():641-52. PubMed ID: 23426652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo.
    Xia HJ; Zhang ZH; Jin X; Hu Q; Chen XY; Jia XB
    Int J Nanomedicine; 2013; 8():545-54. PubMed ID: 23431115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polybasic research on the biopharmaceutical characteristics of 20 (S)-protopanaxadiol].
    Jin X; Zhang ZH; Sun E; Tan XB; Xia HJ; Liu QY; Jia XB
    Yao Xue Xue Bao; 2013 Mar; 48(3):411-6. PubMed ID: 23724657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.
    Ren HC; Sun JG; Wang GJ; A JY; Xie HT; Zha WB; Yan B; Sun FZ; Hao HP; Gu SH; Sheng LS; Shao F; Shi J; Zhou F
    J Pharm Biomed Anal; 2008 Dec; 48(5):1476-80. PubMed ID: 19022601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-microemulsifying Drug Delivery System Improved Oral Bioavailability of 20(S)-Protopanaxadiol: From Preparation to Evaluation.
    Wang B; Pu Y; Xu B; Tao J; Wang Y; Zhang T; Wu P
    Chem Pharm Bull (Tokyo); 2015; 63(9):688-93. PubMed ID: 26084568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on pharmacokinetics of 20 (S) -protopanaxadiol lipid cubic nanoparticles].
    Jin X; Zhang ZH; Sun E; Liu QY; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):263-8. PubMed ID: 23672053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery.
    Chen C; Wang L; Cao F; Miao X; Chen T; Chang Q; Zheng Y
    Int J Pharm; 2016 Jan; 497(1-2):239-47. PubMed ID: 26680316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats.
    Kong LT; Wang Q; Xiao BX; Liao YH; He XX; Ye LH; Liu XM; Chang Q
    Fitoterapia; 2013 Apr; 86():48-53. PubMed ID: 23391424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and Characterization of Novel Dry Suspension and Dry Emulsion of 20(S)-Protopanaxadiol.
    Zhang L; Xu C; Mao J; Wang W; Han H; Pu Y; Zhang T
    AAPS PharmSciTech; 2019 Aug; 20(7):275. PubMed ID: 31388863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
    Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
    Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models.
    Sun H; Bi H; Huang M; Liu D; Qin Z
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):486-94. PubMed ID: 20936649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy.
    Han M; Ma L; Yu X; Li Z; Guo Y; Wang X
    Drug Deliv; 2016 Sep; 23(7):2410-2418. PubMed ID: 25564965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
    Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability.
    Tan QY; Hu NN; Liu GD; Yin HF; Zhang L; Wang H; Lu LY; Zhang JQ
    Arch Pharm Res; 2012 Mar; 35(3):499-508. PubMed ID: 22477197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.
    Lai J; Chen J; Lu Y; Sun J; Hu F; Yin Z; Wu W
    AAPS PharmSciTech; 2009; 10(3):960-6. PubMed ID: 19636709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.